Cornerstone Planning Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cornerstone Planning Group's NVS Position: Q3 2026 in Review
Cornerstone Planning Group sold out of Novartis (NVS) in Q3 2026, closing a stake of 501 shares — an estimated $76.7K sold.
Cornerstone Planning Group first reported a position in NVS in Q4 2022 and held it in 13 quarters. The position peaked at $76.7K in Q2 2026. 447 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Cornerstone Planning Group reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- Cornerstone Planning Group sold 501 Novartis shares in Q3 2026, an estimated $76.7K.
- Cornerstone Planning Group first reported a position in Novartis in Q4 2022 and held it in 13 quarters.
- Cornerstone Planning Group's Novartis position peaked at $76.7K in Q2 2026.
- 447 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.